Novartis realigns pharma division into two new units
BASEL, Switzerland — Making changes to its Pharmaceuticals Division, Novartis has created two business units that will report to the chief executive officer: Novartis Pharmaceuticals and Novartis Oncology. The new units will form the Innovative Medicines Division. Novartis said Tuesday that the new structure reflects the importance of oncology following the integration of oncology assets
